By:
On:
In: Good company, Stock analysis
Tagged:
With: 0 Comments
Company name SINA Corporation (USA)
Stock ticker SINA
Live stock price [stckqut]SINA[/stckqut]
P/E compared to competitors Good
MANAGEMENT EXECUTION
Employee productivity Good
Sales growth Good
EPS growth Good
P/E growth Poor
EBIT growth Good
ANALYSIS
Confident Investor Rating Good
Target stock price (TWCA growth scenario) $143.92
Target stock price (averages with growth) $253.14
Target stock price (averages with no growth) $231.23
Target stock price (manual assumptions) $134.07

The following company description is from Google Finance: http://www.google.com/finance?q=sina
SINA Corporation (SINA) is an online media company and MVAS provider in the People’s Republic of China (PRC) and the global Chinese communities. The Company provides services through five business lines, including SINA.com (online news and content), SINA Mobile (MVAS), SINA Community (Web 2.0 and social networking-based services and games), SINA.net (search and enterprise services), and SINA E-Commerce (online shopping). These business lines provide an array of services, including region-focused online portals, MVAS, social networking service (SNS), such as micro-blog and album, blog, audio and video streaming, album, online games, e-mail, search, classified listings, fee-based services, e-commerce and enterprise e-solutions.

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in this stock.

By:
On:
In: Poor company, Stock analysis
Tagged:
With: 0 Comments
Company name Biomerica, Inc.
Stock ticker BMRA
Live stock price [stckqut]BMRA[/stckqut]
Confident Investor Rating Poor

The following company description is from Google Finance: http://www.google.com/finance?q=bmra
Biomerica, Inc. (Biomerica) develops, manufactures and markets medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. Its medical diagnostic products are sold worldwide in two markets: clinical laboratories and point of care (physicians’ offices and over-the-counter drugstores). Its diagnostic test kits are used to analyze blood or urine from patients in the diagnosis of various diseases and other medical complications, or to measure the level of specific hormones, antibodies, antigens or other substances, which may exist in the human body in extremely small concentrations. The Company?s clinical laboratory diagnostic products include tests for bone and anemia conditions, gastrointestinal diseases, food intolerance, diabetes and others.

Confident Investor comments: At this price and at this time, I do not think that a Confident Investor can confidently invest in this stock. It is not possible to confidently invest in a company that is not currently profitable.

By:
On:
In: Poor company, Stock analysis
Tagged:
With: 0 Comments
Company name Ellomay Capital Ltd.
Stock ticker EMYCF
Live stock price [stckqut]EMYCF[/stckqut]
Confident Investor Rating Poor

The following company description is from Google Finance: http://www.google.com/finance?q=emycf
Ellomay Capital Ltd. (Ellomay) is focused on identifying and evaluating business opportunities and alternatives, including through the acquisition of all or part of an existing business, pursuing business combinations or otherwise. The Company focuses on making investments is the photovoltaic market. The Company was a supplier of wide format and super-wide format digital printing systems worldwide.

Confident Investor comments: At this price and at this time, I do not think that a Confident Investor can confidently invest in this stock. It is not possible to confidently invest in a company that is not currently profitable.

By:
On:
In: Poor company, Stock analysis
Tagged:
With: 0 Comments
Company name Moody’s Corporation
Stock ticker MCO
Live stock price [stckqut]MCO[/stckqut]
P/E compared to competitors Good
MANAGEMENT EXECUTION
Employee productivity Good
Sales growth Poor
EPS growth Poor
P/E growth Poor
EBIT growth Poor
ANALYSIS
Confident Investor Rating Poor
Target stock price (TWCA growth scenario) $18.2
Target stock price (averages with growth) $24.98
Target stock price (averages with no growth) $27.04
Target stock price (manual assumptions) $23.66

The following company description is from Google Finance: http://www.google.com/finance?q=mco
Moody’s Corporation (Moody’s) is a provider of credit ratings; credit and economic related research, data and analytical tools; risk management software, and quantitative credit risk measures, credit portfolio management solutions and training services. The Company operates in two segments: miss and Moody’s Analytics. MIS, the credit rating agency, publishes credit ratings on a range of debt obligations and the entities that issue such obligations in markets worldwide, including various corporate and governmental obligations, structured finance securities and commercial paper programs. Revenue is derived from the originators and issuers of such transactions who use MIS ratings to support the distribution of their debt issues to investors. The MA segment develops a range of products and services that support the risk management activities of institutional participants in global financial markets. In November 2010, the Company acquired CSI Global Education Inc.


Confident Investor comments: At this price and at this time, I do not think that a Confident Investor can confidently invest in this stock.


By:
On:
In: Fair company, Stock analysis
Tagged:
With: 0 Comments
Company name Medco Health Solutions Inc.
Stock ticker MHS
Live stock price [stckqut]MHS[/stckqut]
P/E compared to competitors Fair
MANAGEMENT EXECUTION
Employee productivity Good
Sales growth Fair
EPS growth Good
P/E growth Poor
EBIT growth Good
ANALYSIS
Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $67.03
Target stock price (averages with growth) $90.46
Target stock price (averages with no growth) $75.84
Target stock price (manual assumptions) $78.42

The following company description is from Google Finance: http://www.google.com/finance?q=mhs
Medco Health Solutions, Inc. (Medco) is a healthcare company. It provides clinically-driven pharmacy services designed to improve the quality of care and lower total healthcare costs for private and public employers, health plans, labor unions and government agencies of all sizes, and for individuals served by Medicare Part D Prescription Drug Plans. During the fiscal year ended December 26, 2009 (fiscal 2009), the Company administered 695 million prescriptions. In January 2010, the Company completed the acquisition of DNA Direct Inc. In April 2008, Medco acquired a majority interest in Europa Apotheek Venlo B.V. (Europa Apotheek), which provides mail-order pharmacy services in Germany. In 2009, Medco formed a joint venture with United Drug plc, a pan-European healthcare provider, to provide home-based pharmacy care services in the United Kingdom for patients covered by the country’s National Health Service.


Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in this stock as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.